32
Participants
Start Date
February 12, 2019
Primary Completion Date
September 1, 2020
Study Completion Date
September 1, 2020
Placebo (twice daily)
Matching placebo
Nicotinamide Riboside/Pterostilbene (500 mg/100 mg twice daily)
Elysium Basis TM, Elysium Health, Inc., NY, USA
Aarhus University Hospital, Aarhus N
University of Copenhagen
OTHER
University of Aarhus
OTHER